Laura‐Kate Shaw

552 total citations
17 papers, 424 citations indexed

About

Laura‐Kate Shaw is a scholar working on Oncology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura‐Kate Shaw has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in General Health Professions and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura‐Kate Shaw's work include BRCA gene mutations in cancer (4 papers), Global Cancer Incidence and Screening (4 papers) and Parasite Biology and Host Interactions (4 papers). Laura‐Kate Shaw is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Global Cancer Incidence and Screening (4 papers) and Parasite Biology and Host Interactions (4 papers). Laura‐Kate Shaw collaborates with scholars based in Australia, United Kingdom and United States. Laura‐Kate Shaw's co-authors include Kerry A. Sherman, I. Fairweather, John Boyages, Diana Harcourt, Thomas Lam, Elisabeth Elder, G.P. Brennan, Linda D. Cameron, Caleb J. Winch and Julie Fitness and has published in prestigious journals such as Plastic & Reconstructive Surgery, The Journal of Nervous and Mental Disease and Psycho-Oncology.

In The Last Decade

Laura‐Kate Shaw

17 papers receiving 423 citations

Peers

Laura‐Kate Shaw
Margaret M. McNeill United States
Suad M. Sulaiman Sudan
Earnest Njih Tabah Cameroon
Anneloes van den Broek Netherlands
Mary Fraser United Kingdom
Oladele Akogun Nigeria
Helen Chapman Australia
Obioma C. Nwaorgu Nigeria
Hayley Mableson United Kingdom
Margaret M. McNeill United States
Laura‐Kate Shaw
Citations per year, relative to Laura‐Kate Shaw Laura‐Kate Shaw (= 1×) peers Margaret M. McNeill

Countries citing papers authored by Laura‐Kate Shaw

Since Specialization
Citations

This map shows the geographic impact of Laura‐Kate Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura‐Kate Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura‐Kate Shaw more than expected).

Fields of papers citing papers by Laura‐Kate Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura‐Kate Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura‐Kate Shaw. The network helps show where Laura‐Kate Shaw may publish in the future.

Co-authorship network of co-authors of Laura‐Kate Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Laura‐Kate Shaw. A scholar is included among the top collaborators of Laura‐Kate Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura‐Kate Shaw. Laura‐Kate Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sherman, Kerry A. & Laura‐Kate Shaw. (2018). Body Image and the Cancer Treatment Trajectory. Oxford University Press eBooks. 1 indexed citations
2.
Parkinson, Bonny, Kerry A. Sherman, Paul Brown, et al.. (2018). Cost‐effectiveness of the BRECONDA decision aid for women with breast cancer: Results from a randomized controlled trial. Psycho-Oncology. 27(6). 1589–1596. 14 indexed citations
3.
Sherman, Kerry A., Christopher J. Kilby, Laura‐Kate Shaw, et al.. (2017). Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results. The Breast. 36. 79–85. 22 indexed citations
4.
Sherman, Kerry A., et al.. (2017). The importance of coherently understanding cervical cancer vaccination: factors associated with young Australian women’s uptake of the HPV vaccine. Health Psychology and Behavioral Medicine. 5(1). 358–371. 4 indexed citations
5.
Shaw, Laura‐Kate, et al.. (2016). Women's experiences of dating after breast cancer. Journal of Psychosocial Oncology. 34(4). 318–335. 17 indexed citations
6.
Sherman, Kerry A., Laura‐Kate Shaw, Caleb J. Winch, et al.. (2016). Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled Trial. Plastic & Reconstructive Surgery. 138(4). 592e–602e. 61 indexed citations
7.
Sherman, Kerry A., Laura‐Kate Shaw, Lone Jørgensen, et al.. (2016). Qualitatively understanding patients' and health professionals' experiences of the BRECONDA breast reconstruction decision aid. Psycho-Oncology. 26(10). 1618–1624. 18 indexed citations
8.
Shaw, Laura‐Kate, Kerry A. Sherman, & Julie Fitness. (2015). Dating concerns among women with breast cancer or with genetic breast cancer susceptibility: a review and meta-synthesis. Health Psychology Review. 9(4). 491–505. 12 indexed citations
9.
Sherman, Kerry A., et al.. (2015). The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services. Journal of Behavioral Medicine. 38(5). 706–714. 7 indexed citations
10.
Shaw, Laura‐Kate & Judi Homewood. (2015). The Effect of Eating Disorder Memoirs in Individuals With Self-Identified Eating Pathologies. The Journal of Nervous and Mental Disease. 203(8). 591–595. 15 indexed citations
11.
Sherman, Kerry A., Diana Harcourt, Thomas Lam, Laura‐Kate Shaw, & John Boyages. (2014). BRECONDA: Development and acceptability of an interactive decisional support tool for women considering breast reconstruction. Psycho-Oncology. 23(7). 835–838. 35 indexed citations
12.
Sherman, Kerry A., et al.. (2013). Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review. Journal of Community Genetics. 5(2). 89–98. 18 indexed citations
13.
Sherman, Kerry A., et al.. (2013). Fatalism and Health Promoting Behaviors in Chinese and Korean Immigrants and Caucasians. Journal of Immigrant and Minority Health. 17(1). 165–171. 31 indexed citations
14.
15.
Fairweather, I., et al.. (2011). Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: Proof of concept. Veterinary Parasitology. 183(3-4). 249–259. 59 indexed citations
16.
Álvarez, Luis, Laura Moreno, Laura Ceballos, et al.. (2009). Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Veterinary Parasitology. 164(2-4). 211–216. 56 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret M. McNeill Breakdown of academic impact, for papers by Suad M. Sulaiman Breakdown of academic impact, for papers by Earnest Njih Tabah Breakdown of academic impact, for papers by Anneloes van den Broek Breakdown of academic impact, for papers by Mary Fraser Breakdown of academic impact, for papers by Oladele Akogun Breakdown of academic impact, for papers by Helen Chapman Breakdown of academic impact, for papers by Obioma C. Nwaorgu Breakdown of academic impact, for papers by Hayley Mableson
Rankless by CCL
2026